title: Neither guidelines nor symptom-targeted opioids are harmful when withdrawing life-sustaining measures.
authors.affiliation: Division of Critical Care, Department of Medicine, University of Toronto, 200 Elizabeth St. 9 N-926, Toronto, ON, M5G 2C4, Canada. james.downar@utoronto.ca.
authors.forename: James
authors.initials: J
authors.lastname: Downar
authors.affiliation: Division of Critical Care, Department of Medicine, University of Toronto, 200 Elizabeth St. 9 N-926, Toronto, ON, M5G 2C4, Canada.
authors.forename: Jesse
authors.initials: J
authors.lastname: Delaney
authors.affiliation: Division of Critical Care, Department of Medicine, University of Toronto, 200 Elizabeth St. 9 N-926, Toronto, ON, M5G 2C4, Canada.
authors.forename: Laura
authors.initials: L
authors.lastname: Hawryluck
authors.affiliation: Division of Critical Care, Department of Medicine, University of Toronto, 200 Elizabeth St. 9 N-926, Toronto, ON, M5G 2C4, Canada.
authors.forename: Lisa
authors.initials: L
authors.lastname: Kenny
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D006801:Humans; D008020:Life Support Care / Q000592:standards*; D010146:Pain / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D028761:Withholding Treatment / Q000592:standards*
chemical_list: D000701:Analgesics, Opioid